FTC

PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating
Drug Channels
Tue, 07/16/24 - 12:01 pm
FTC
PBMs
FTC poised to sue drug middlemen over insulin prices
Axios
Fri, 07/12/24 - 11:30 am
FTC
PBMs
insulin
diabetes
drug pricing
legal
CVS Caremark
Express Scripts
OptumRx
FTC report finds PBM power has “dire consequences”
Pharmaphorum
Tue, 07/9/24 - 11:22 am
FTC
PBMs
supply chain
FTC opens investigation into Teva, escalating patent fight with pharma industry
Washington Post, DC
Mon, 07/1/24 - 10:02 pm
FTC
Teva Pharmaceutical
patents
inhalers
FTC Supports PTO Push for Patent Settlement Scrutiny, Better Antitrust Oversight
BioSpace
Thu, 06/20/24 - 11:25 am
FTC
patents
antitrust
FTC backs rule change that could expose anticompetitive drug patent deals
First Word Pharma
Tue, 06/18/24 - 08:00 pm
FTC
antitrust
patents
regulatory
FTC request may signal trouble for Novo/Catalent deal
Pharma Voice
Thu, 05/30/24 - 11:09 am
Novo Holdings
Catalent
FTC
M&A
Maze lands new partner for Pompe drug, after Sanofi pact came apart
BioPharma Dive
Fri, 05/10/24 - 11:29 am
Maze Therapeutics
Pompe disease
Shionogi
FTC
Sanofi
MZE001
FTC seeks more information on Novo Nordisk parent-Catalent deal
Reuters
Fri, 05/3/24 - 11:28 am
FTC
Novo Nordisk
Catalent
M&A
GSK defends itself—again—after senator argues it withdrew popular asthma med to dodge price caps and Medicaid rebates
Fierce Pharma
Fri, 05/3/24 - 11:26 am
GSK
FTC
patents
Senate
FTC crackdown on ‘bogus’ patents hits Novo’s Ozempic, GSK’s Trelegy Ellipta
Medical Marketing and Media
Fri, 05/3/24 - 11:10 am
FTC
patents
Orange Book
Novo Nordisk
Ozempic
GSK
Trelegy Ellipta
FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal
Reuters
Thu, 04/4/24 - 10:57 am
Boston Scientific
Medtech
FTC
M&A
Axonics
FTC weighs in on Teva's inhaler litigation against Amneal amid far-reaching patent crackdown
Fierce Pharma
Mon, 03/25/24 - 11:25 am
FTC
patents
legal
Teva Pharmaceutical
Amneal
Congressional lawmakers strike back at Biden admin's 'march-in' proposal to corral drug costs
Fierce Pharma
Fri, 02/23/24 - 10:24 am
Joe Biden
FTC
march-in rights
congress
drug pricing
AbbVie’s Cerevel deal hits an uncommon roadblock
BioPharma Dive
Wed, 02/21/24 - 11:10 am
AbbVie
Cerevel Therapeutics
M&A
FTC
antitrust
FTC probing middlemen's role in drug shortages
Axios
Fri, 02/16/24 - 11:23 am
FTC
HHS
drug shortages
PBMs
generics
supply chain
FTC and HHS Launch Probe of Ongoing Generic Drug Shortages
BioSpace
Wed, 02/14/24 - 06:41 pm
drug shortages
FTC
HHS
generics
FTC’s Misguided Antitrust Regulation Threatens Pharma Innovation
Forbes
Wed, 02/14/24 - 11:25 am
FTC
antitrust
innovation
FTC calls for 'expansive and flexible' use of march-in rights to rein in
Fierce Pharma
Tue, 02/6/24 - 11:35 pm
FTC
march-in rights
patents
The FTC is attacking drugmakers’ ‘patent thickets’
Medical Marketing and Media
Wed, 01/31/24 - 10:24 pm
FTC
patents
patent thickets

Pages